March 13, 2018 | Denise Heady
Fourteen years ago, neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., began to travel to underserved countries to perform brain surgeries on disadvantaged children.
City of Hope's Ravi Salgia Discovers New Biomarker Link in Nonsmall Cell Lung Cancer
December 7, 2017 | Elise Lamar
Ravi Salgia, M.D., Ph.D., recently published in Scientific Reports about a novel and promising link between two NSCLC biomarkers. The study might help oncologists match patients with effective drug interventions against specific forms of NSCLC.
Custom Care: Personalized Treatment for Breast Cancer
July 21, 2017 | City of Hope
The term “personalized” gets used a lot in medicine these days. If you’ve received a breast cancer diagnosis, you’re probably wondering what personalized breast cancer care really means.
Targeted Therapy 101: A Primer
July 17, 2017 | City of Hope
Cancer care has come a long way. Surgery, chemotherapy and radiation have traditionally been the three pillars of cancer care, and they are still important treatments. But in recent years, newer “targeted therapies” have come on the scene.
City of Hope collaborates with The Jackson Laboratory to help speed research discoveries into cures
July 11, 2017 | Denise Heady
A collaboration with The Jackson Laboratory expands access to leading-edge research capabilities to find new treatments for life-threatening diseases.
Liquid Biopsy Offers a New Way to Target Kidney Cancer
February 17, 2017 | Denise Heady
Despite a wave of new targeted therapies being approved to treat kidney cancer, many of those therapies have been challenging to use because of the difficulty in obtaining cancer tissue for genomic testing. Now, researchers may have found a way to combat this problem: the liquid biopsy.
Advances: New Immunotherapy Treatments for Breast Cancer in 2017
December 23, 2016 | Katie Neith
Peter P. Lee, M.D., a City of Hope oncologist, has for 20 years been interested in treating cancer by stimulating or enhancing a person’s own immune system. This approach, called immunotherapy, has gained much attention in recent years. Lee's outlook for 2017 is full of promise for a more personalized approach to the disease.
City of Hope's Steven T. Rosen, M.D., on the Impact of the TGen Alliance
December 1, 2016 | City of Hope
In this Q and A, Steven T. Rosen, M.D., provost and chief scientific officer for City of Hope, answers questions about the importance of precision of medicine in the fight against cancer and how the City of Hope and TGen alliance will advance research and treatment using this approach.
City of Hope Joins Forces with TGen to Bring More Firepower to the Fight Against Cancer
November 30, 2016 | City of Hope
City of Hope is joining forces with the Translational Genomics Research Institute (TGen) to accelerate the speed with which scientists and medical staff can convert research discoveries into cures for patients.